Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [Phase 3]
Phase 3 immunogenicity and safety study of GlaxoSmithKline's combined measles-mumps-rubella-varicella vaccine has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Safety Study of NBP608 in Healthy Adult Volunteers [Phase 1]
Phase 1 safety study of NBP608 in healthy adult volunteers has completed; the trial assesses safety and tolerability in contexts related to …
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age [Phase 2]
Phase 2 trial update evaluating the immunogenicity and safety of NBP608 in healthy children aged 12 months to 12 years for Varicella has bee…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) [Phase 2]
Phase 2 trial results assessing the safety, tolerability, and immunogenicity of an investigational recombinant human albumin (rHA)–based vac…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Safety Study of a Refrigerator-stable Formulation of VARIVAX® [Phase 4]
The document reports the completion of a Phase 4 safety study of a refrigerator-stable formulation of VARIVAX (varicella vaccine) sponsored …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients [Phase 1]
This Phase 1 study evaluated the safety of Varivax in pediatric renal transplant recipients and was terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
A completed NIAID-sponsored trial evaluated the immune response to the varicella vaccine in children with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of PriorixTetra when co-administered with a conjugated MenC vaccine in healthy children; …
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]
Phase 2 study assessing immunogenicity and safety of a combined Measles-Mumps-Rubella-Varicella vaccine (MeMuRu-OKA) compared with Priorix (…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of the MeMuRu-OKA measles-mumps-rubella-varicella vaccine compared with Priorix given…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine. The study has completed…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]
A Phase 3 trial assessed the immunogenicity and safety of a combined measles, mumps, rubella and varicella vaccine (MMRV) developed by Glaxo…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 4]
This Phase 4 trial update reports on the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine developed by…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [Phase 3]
This document reports long-term immunogenicity and safety results from a Phase 3 trial of the MMRV vaccine, evaluating durability of immune …
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. [Phase 3]
Phase 3 trial evaluating immunogenicity, reactogenicity and safety of a combined Measles, Mumps and Rubella vaccine produced by Bio-Manguinh…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063) [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of VARIVAX New Seed Process in children with varicella has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) [Phase 3]
This update reports the completion of a Phase 3 study evaluating Merck's Measles, Mumps, Rubella, and Varicella vaccine (ProQuad) in healthy…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: MMR and Varicella Vaccine in Premature Infants
A completed clinical trial evaluating the MMR vaccine and the varicella vaccine in premature infants.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: ZOSTAVAX(R) Local Registration Trial (V211-019) [Phase 3]
Phase 3 trial update for ZOSTAVAX in Varicella virus infection (NCT00444860) with status COMPLETED.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Evaluation Of Valaciclovir In Patients With Chickenpox [Phase 3]
A Phase 3 clinical trial evaluating valaciclovir for varicella (chickenpox) has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine [Phase 4]
A Phase 4 trial evaluated immunogenicity and safety of two doses of a live attenuated varicella vaccine. The study has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of an alternative manufacturing process for MMRV vaccine (AMP) with comple…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine [Phase 4]
A Phase 4 clinical trial evaluating the effectiveness of a two-dose live attenuated varicella vaccine; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children [Phase 4]
Phase 4 clinical trial update evaluating immune persistence after a one-dose freeze-dried live attenuated varicella vaccine in children.
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Re-examination Study For Varivax (V210-059 AM2)
This clinical trial update reports the completion and posting of results for a re-examination study of Varivax (V210-059 AM2). The results w…